NASDAQ

Immunome, Inc. (IMNM)

♥ 605 Thanks from members

Live price chart, market sentiment, and community perspectives for Immunome, Inc. (NASDAQ: IMNM).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Immunome FoundersLeadership: Clayton Robertson (CEO)Holder: Redmile GroupHolder: RA Capital ManagementOncology TherapeuticsImmunotherapy Pipeline#IMNM#Immunome#Biotech Stock#Oncology Pipeline#Antibody Discovery